![Babbage from The Economist artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts123/v4/d7/de/eb/d7deeb7a-2284-b91a-5aa3-4a2af9ad9d39/mza_1715357569881946795.jpg/100x100bb.jpg)
Babbage: Another dose of good news
Babbage from The Economist
English - November 25, 2020 18:12 - 30 minutes - 68.8 MB - ★★★★★ - 398 ratingsTech News News science and technology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Babbage: A grand bargain for tech
Next Episode: Babbage: Testing testing
Following promising results from Pfizer and Moderna, why is a third vaccine, from Oxford University and AstraZeneca, so important in the fight against covid-19? Host Kenneth Cukier and The Economist’s health policy editor Natasha Loder investigate the different approaches to this immense challenge. And Nicholas Christakis, a doctor and network scientist at Yale University, explains how despite a vaccine the pandemic could change humanity for good.
Please subscribe to The Economist for full access to print, digital and audio editions:
www.economist.com/podcastoffer
Hosted on Acast. See acast.com/privacy for more information.